Citadel Advisors »

Plus Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $19k 11k 1.81
2023-12-31 $30k 17k 1.79

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Plus Therapeutics

Vanguard Group
Geode Capital Management
Citadel Advisors
BlackRock
Tower Research Capital
Advisor Group Holdings
Jpmorgan Chase & Co
Wells Fargo & Company
Group One Trading

View all funds holding Plus Therapeutics